Cardiovascular Sciences, Inc. (CVSC)

Cardiovascular Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2008	FY 2007	FY 2006	FY 2003	FY 2002
Period Ending	Mar 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2003	Dec 31, 2002
Revenue	0.26	0.32	0.14	0.25	0.15	0.06
Revenue Growth (YoY)	849.58%	131.41%	-44.84%	72.31%	141.92%	-
Gross Profit	0.26	0.32	0.14	0.25	0.15	0.06
Selling, General & Admin	0.11	0.12	0.1	0.29	1.51	0.24
Research & Development	-	-	-	0.06	-	-
Other Operating Expenses	0.02	0.02	0.01	-	-	-
Operating Expenses	0.13	0.14	0.1	0.35	1.51	0.24
Operating Income	0.13	0.18	0.03	-0.1	-1.37	-0.18
Interest Expense	-	-	-	-	-0.03	-0.02
Interest & Investment Income	0.12	0.05	0.14	0.14	-	-
Other Non Operating Income (Expenses)	-	-	-	-0.01	-	-
EBT Excluding Unusual Items	0.25	0.22	0.17	0.03	-1.4	-0.2
Other Unusual Items	-0.03	-0.05	-	-	-	-
Pretax Income	0.23	0.18	0.17	0.03	-1.4	-0.2
Income Tax Expense	0.01	0.01	0.02	0.04	-	-
Earnings From Continuing Operations	0.22	0.17	0.15	-0	-1.4	-0.2
Earnings From Discontinued Operations	-	-	-	-	-	0.12
Net Income	0.22	0.17	0.15	-0	-1.4	-0.08
Net Income to Common	0.22	0.17	0.15	-0	-1.4	-0.08
Net Income Growth	-	14.42%	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	50.78%	55.72%	24.97%	-39.38%	-933.91%	-291.41%
Profit Margin	85.31%	52.71%	106.61%	-1.32%	-956.13%	-126.23%
EBITDA	-	-	-	-	-1.36	-0.17
EBITDA Margin	-	-	-	-	-	-281.40%
D&A For EBITDA	-	-	-	-	0.01	0.01
EBIT	0.13	0.18	0.03	-0.1	-1.37	-0.18
EBIT Margin	50.78%	55.72%	24.97%	-39.38%	-	-291.41%
Effective Tax Rate	2.78%	4.05%	13.77%	110.40%	-	-
Revenue as Reported	0.37	0.37	0.28	0.39	0.15	0.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.